Pyridostigmine Bromide
Pyridostigmine Bromide Tablets, USP (30 mg) Rx only
Approved
Approval ID
91ca7bcf-d2cc-4cb3-bfbe-c294fd707524
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 31, 2023
Manufacturers
FDA
Amneal Pharmaceuticals of New York LLC
DUNS: 123797875
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
PYRIDOSTIGMINE BROMIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0115-2134
Application NumberANDA040502
Product Classification
M
Marketing Category
C73584
G
Generic Name
PYRIDOSTIGMINE BROMIDE
Product Specifications
Route of AdministrationORAL
Effective DateDecember 31, 2023
FDA Product Classification
INGREDIENTS (5)
PYRIDOSTIGMINE BROMIDEActive
Quantity: 30 mg in 1 1
Code: KVI301NA53
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT